Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus

It has been shown that ouabain (OUA) can activate the Na,K‐ATPase complex and mediate intracellular signaling in the central nervous system (CNS). Inflammatory stimulus increases glutamatergic transmission, especially at N‐methyl‐D‐aspartate (NMDA) receptors, which are usually coupled to the activat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuroscience research 2012-01, Vol.90 (1), p.213-228
Hauptverfasser: Kawamoto, E.M., Lima, L.S., Munhoz, C.D., Yshii, L.M., Kinoshita, P.F., Amara, F.G., Pestana, R.R.F., Orellana, A.M.M., Cipolla-Neto, J., Britto, L.R.G., Avellar, M.C.W., Rossoni, L.V., Scavone, C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 228
container_issue 1
container_start_page 213
container_title Journal of neuroscience research
container_volume 90
creator Kawamoto, E.M.
Lima, L.S.
Munhoz, C.D.
Yshii, L.M.
Kinoshita, P.F.
Amara, F.G.
Pestana, R.R.F.
Orellana, A.M.M.
Cipolla-Neto, J.
Britto, L.R.G.
Avellar, M.C.W.
Rossoni, L.V.
Scavone, C.
description It has been shown that ouabain (OUA) can activate the Na,K‐ATPase complex and mediate intracellular signaling in the central nervous system (CNS). Inflammatory stimulus increases glutamatergic transmission, especially at N‐methyl‐D‐aspartate (NMDA) receptors, which are usually coupled to the activation of nitric oxide synthase (NOS). Nuclear factor‐κB (NF‐κB) activation modulates the expression of genes involved in development, plasticity, and inflammation. The present work investigated the effects of OUA on NF‐κB binding activity in rat hippocampus and the influence of this OUA‐Na,K‐ATPase signaling cascade in NMDA‐mediated NF‐κB activation. The findings presented here are the first report indicating that intrahippocampal administration of OUA, in a concentration that did not alter Na,K‐ATPase or NOS activity, induced an activation of NF‐κB, leading to increases in brain‐derived neurotrophic factor (Bdnf), inducible NOS (iNos), tumor necrosis factor‐α (Tnf‐α), and B‐cell leukemia/lymphoma 2 (Bcl2) mRNA levels. This response was not linked to any significant signs of neurodegeneration as showed via Fluoro‐Jade B and Nissl stain. Intrahippocampal administration of NMDA induced NF‐κB activation and increased NOS and α2/3‐Na,K‐ATPase activities. NMDA treatment further increased OUA‐induced NF‐κB activation, which was partially blocked by MK‐801, an antagonist of NMDA receptor. These results suggest that OUA‐induced NF‐κB activation is at least in part dependent on Na,K‐ATPase modulatory action of NMDA receptor in hippocampus. The interaction of these signaling pathways could be associated with biological mechanisms that may underlie the basal homeostatic state linked to the inflammatory signaling cascade in the brain. © 2011 Wiley Periodicals, Inc.
doi_str_mv 10.1002/jnr.22745
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_905671410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>905671410</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3625-c594326e55671aaae2a542bad988ed0ebba15db392ce759361271d4d26243adf3</originalsourceid><addsrcrecordid>eNp1kM1u1DAURi1ERYfCghdA3iEWbv2bjJe0hbZoNBUFxNK6cW40KUkcbAeYV-MheKZmmLY7Vle6Ot9ZHEJeCX4sOJcnt0M8lrLU5glZCG5Lpo0un5IFVwVnmgt5SJ6ndMs5t9aoZ-RQSs6LolwuyHA1NN2Eg0caGrpmPebNtmPnDNIIMUNGGtHjmENMNAw0TFBBO1Dwuf0Jud29GjpMvkOItJnfIbK_f07pzOTNPIZMN-04Bg_9OKUX5KCBLuHL-3tEvn54_-Xskq2uL67O3q2YV4U0zBurlSzQmKIUAIASjJYV1Ha5xJpjVYEwdaWs9FgaqwohS1HrWhZSK6gbdUTe7L1jDD8mTNn1bfLYdTBgmJKzfGfWgs_k2z3pY0gpYuPG2PYQt05wt6vr5rruX92ZfX1vnaoe60fyIecMnOyBX22H2_-b3Mf1zYOS7Rdtyvj7cQHxuytKVRr3bX3hPtmbz6crxd25ugOl_pSY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>905671410</pqid></control><display><type>article</type><title>Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kawamoto, E.M. ; Lima, L.S. ; Munhoz, C.D. ; Yshii, L.M. ; Kinoshita, P.F. ; Amara, F.G. ; Pestana, R.R.F. ; Orellana, A.M.M. ; Cipolla-Neto, J. ; Britto, L.R.G. ; Avellar, M.C.W. ; Rossoni, L.V. ; Scavone, C.</creator><creatorcontrib>Kawamoto, E.M. ; Lima, L.S. ; Munhoz, C.D. ; Yshii, L.M. ; Kinoshita, P.F. ; Amara, F.G. ; Pestana, R.R.F. ; Orellana, A.M.M. ; Cipolla-Neto, J. ; Britto, L.R.G. ; Avellar, M.C.W. ; Rossoni, L.V. ; Scavone, C.</creatorcontrib><description>It has been shown that ouabain (OUA) can activate the Na,K‐ATPase complex and mediate intracellular signaling in the central nervous system (CNS). Inflammatory stimulus increases glutamatergic transmission, especially at N‐methyl‐D‐aspartate (NMDA) receptors, which are usually coupled to the activation of nitric oxide synthase (NOS). Nuclear factor‐κB (NF‐κB) activation modulates the expression of genes involved in development, plasticity, and inflammation. The present work investigated the effects of OUA on NF‐κB binding activity in rat hippocampus and the influence of this OUA‐Na,K‐ATPase signaling cascade in NMDA‐mediated NF‐κB activation. The findings presented here are the first report indicating that intrahippocampal administration of OUA, in a concentration that did not alter Na,K‐ATPase or NOS activity, induced an activation of NF‐κB, leading to increases in brain‐derived neurotrophic factor (Bdnf), inducible NOS (iNos), tumor necrosis factor‐α (Tnf‐α), and B‐cell leukemia/lymphoma 2 (Bcl2) mRNA levels. This response was not linked to any significant signs of neurodegeneration as showed via Fluoro‐Jade B and Nissl stain. Intrahippocampal administration of NMDA induced NF‐κB activation and increased NOS and α2/3‐Na,K‐ATPase activities. NMDA treatment further increased OUA‐induced NF‐κB activation, which was partially blocked by MK‐801, an antagonist of NMDA receptor. These results suggest that OUA‐induced NF‐κB activation is at least in part dependent on Na,K‐ATPase modulatory action of NMDA receptor in hippocampus. The interaction of these signaling pathways could be associated with biological mechanisms that may underlie the basal homeostatic state linked to the inflammatory signaling cascade in the brain. © 2011 Wiley Periodicals, Inc.</description><identifier>ISSN: 0360-4012</identifier><identifier>EISSN: 1097-4547</identifier><identifier>DOI: 10.1002/jnr.22745</identifier><identifier>PMID: 22006678</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Analysis of Variance ; Animals ; bcl-2-Associated X Protein - genetics ; bcl-2-Associated X Protein - metabolism ; Brain-Derived Neurotrophic Factor - genetics ; Brain-Derived Neurotrophic Factor - metabolism ; Cell Death - drug effects ; Dizocilpine Maleate - pharmacology ; Dose-Response Relationship, Drug ; Drug Interactions ; Electrophoretic Mobility Shift Assay - methods ; Enzyme Activation - drug effects ; Enzyme Inhibitors - pharmacology ; Excitatory Amino Acid Antagonists - pharmacology ; Gene Expression Regulation, Enzymologic - drug effects ; glutamate ; Hippocampus - cytology ; Hippocampus - drug effects ; K-ATPase ; Male ; N-methyl-D-aspartate ; N-Methylaspartate - pharmacology ; Na,K‐ATPase ; Neurons - cytology ; Neurons - drug effects ; NF-kappa B - metabolism ; NF-κB ; Nitric Oxide Synthase Type II - genetics ; Nitric Oxide Synthase Type II - metabolism ; Oligonucleotides - pharmacology ; ouabain ; Ouabain - pharmacology ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Rats ; Rats, Wistar ; Receptors, N-Methyl-D-Aspartate - metabolism ; RNA, Messenger - metabolism ; Sodium-Potassium-Exchanging ATPase - metabolism ; Time Factors ; Tumor Necrosis Factor-alpha - genetics ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Journal of neuroscience research, 2012-01, Vol.90 (1), p.213-228</ispartof><rights>Copyright © 2011 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3625-c594326e55671aaae2a542bad988ed0ebba15db392ce759361271d4d26243adf3</citedby><cites>FETCH-LOGICAL-c3625-c594326e55671aaae2a542bad988ed0ebba15db392ce759361271d4d26243adf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjnr.22745$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjnr.22745$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22006678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawamoto, E.M.</creatorcontrib><creatorcontrib>Lima, L.S.</creatorcontrib><creatorcontrib>Munhoz, C.D.</creatorcontrib><creatorcontrib>Yshii, L.M.</creatorcontrib><creatorcontrib>Kinoshita, P.F.</creatorcontrib><creatorcontrib>Amara, F.G.</creatorcontrib><creatorcontrib>Pestana, R.R.F.</creatorcontrib><creatorcontrib>Orellana, A.M.M.</creatorcontrib><creatorcontrib>Cipolla-Neto, J.</creatorcontrib><creatorcontrib>Britto, L.R.G.</creatorcontrib><creatorcontrib>Avellar, M.C.W.</creatorcontrib><creatorcontrib>Rossoni, L.V.</creatorcontrib><creatorcontrib>Scavone, C.</creatorcontrib><title>Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus</title><title>Journal of neuroscience research</title><addtitle>J. Neurosci. Res</addtitle><description>It has been shown that ouabain (OUA) can activate the Na,K‐ATPase complex and mediate intracellular signaling in the central nervous system (CNS). Inflammatory stimulus increases glutamatergic transmission, especially at N‐methyl‐D‐aspartate (NMDA) receptors, which are usually coupled to the activation of nitric oxide synthase (NOS). Nuclear factor‐κB (NF‐κB) activation modulates the expression of genes involved in development, plasticity, and inflammation. The present work investigated the effects of OUA on NF‐κB binding activity in rat hippocampus and the influence of this OUA‐Na,K‐ATPase signaling cascade in NMDA‐mediated NF‐κB activation. The findings presented here are the first report indicating that intrahippocampal administration of OUA, in a concentration that did not alter Na,K‐ATPase or NOS activity, induced an activation of NF‐κB, leading to increases in brain‐derived neurotrophic factor (Bdnf), inducible NOS (iNos), tumor necrosis factor‐α (Tnf‐α), and B‐cell leukemia/lymphoma 2 (Bcl2) mRNA levels. This response was not linked to any significant signs of neurodegeneration as showed via Fluoro‐Jade B and Nissl stain. Intrahippocampal administration of NMDA induced NF‐κB activation and increased NOS and α2/3‐Na,K‐ATPase activities. NMDA treatment further increased OUA‐induced NF‐κB activation, which was partially blocked by MK‐801, an antagonist of NMDA receptor. These results suggest that OUA‐induced NF‐κB activation is at least in part dependent on Na,K‐ATPase modulatory action of NMDA receptor in hippocampus. The interaction of these signaling pathways could be associated with biological mechanisms that may underlie the basal homeostatic state linked to the inflammatory signaling cascade in the brain. © 2011 Wiley Periodicals, Inc.</description><subject>Analysis of Variance</subject><subject>Animals</subject><subject>bcl-2-Associated X Protein - genetics</subject><subject>bcl-2-Associated X Protein - metabolism</subject><subject>Brain-Derived Neurotrophic Factor - genetics</subject><subject>Brain-Derived Neurotrophic Factor - metabolism</subject><subject>Cell Death - drug effects</subject><subject>Dizocilpine Maleate - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Interactions</subject><subject>Electrophoretic Mobility Shift Assay - methods</subject><subject>Enzyme Activation - drug effects</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Gene Expression Regulation, Enzymologic - drug effects</subject><subject>glutamate</subject><subject>Hippocampus - cytology</subject><subject>Hippocampus - drug effects</subject><subject>K-ATPase</subject><subject>Male</subject><subject>N-methyl-D-aspartate</subject><subject>N-Methylaspartate - pharmacology</subject><subject>Na,K‐ATPase</subject><subject>Neurons - cytology</subject><subject>Neurons - drug effects</subject><subject>NF-kappa B - metabolism</subject><subject>NF-κB</subject><subject>Nitric Oxide Synthase Type II - genetics</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Oligonucleotides - pharmacology</subject><subject>ouabain</subject><subject>Ouabain - pharmacology</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, N-Methyl-D-Aspartate - metabolism</subject><subject>RNA, Messenger - metabolism</subject><subject>Sodium-Potassium-Exchanging ATPase - metabolism</subject><subject>Time Factors</subject><subject>Tumor Necrosis Factor-alpha - genetics</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0360-4012</issn><issn>1097-4547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM1u1DAURi1ERYfCghdA3iEWbv2bjJe0hbZoNBUFxNK6cW40KUkcbAeYV-MheKZmmLY7Vle6Ot9ZHEJeCX4sOJcnt0M8lrLU5glZCG5Lpo0un5IFVwVnmgt5SJ6ndMs5t9aoZ-RQSs6LolwuyHA1NN2Eg0caGrpmPebNtmPnDNIIMUNGGtHjmENMNAw0TFBBO1Dwuf0Jud29GjpMvkOItJnfIbK_f07pzOTNPIZMN-04Bg_9OKUX5KCBLuHL-3tEvn54_-Xskq2uL67O3q2YV4U0zBurlSzQmKIUAIASjJYV1Ha5xJpjVYEwdaWs9FgaqwohS1HrWhZSK6gbdUTe7L1jDD8mTNn1bfLYdTBgmJKzfGfWgs_k2z3pY0gpYuPG2PYQt05wt6vr5rruX92ZfX1vnaoe60fyIecMnOyBX22H2_-b3Mf1zYOS7Rdtyvj7cQHxuytKVRr3bX3hPtmbz6crxd25ugOl_pSY</recordid><startdate>201201</startdate><enddate>201201</enddate><creator>Kawamoto, E.M.</creator><creator>Lima, L.S.</creator><creator>Munhoz, C.D.</creator><creator>Yshii, L.M.</creator><creator>Kinoshita, P.F.</creator><creator>Amara, F.G.</creator><creator>Pestana, R.R.F.</creator><creator>Orellana, A.M.M.</creator><creator>Cipolla-Neto, J.</creator><creator>Britto, L.R.G.</creator><creator>Avellar, M.C.W.</creator><creator>Rossoni, L.V.</creator><creator>Scavone, C.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201201</creationdate><title>Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus</title><author>Kawamoto, E.M. ; Lima, L.S. ; Munhoz, C.D. ; Yshii, L.M. ; Kinoshita, P.F. ; Amara, F.G. ; Pestana, R.R.F. ; Orellana, A.M.M. ; Cipolla-Neto, J. ; Britto, L.R.G. ; Avellar, M.C.W. ; Rossoni, L.V. ; Scavone, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3625-c594326e55671aaae2a542bad988ed0ebba15db392ce759361271d4d26243adf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Analysis of Variance</topic><topic>Animals</topic><topic>bcl-2-Associated X Protein - genetics</topic><topic>bcl-2-Associated X Protein - metabolism</topic><topic>Brain-Derived Neurotrophic Factor - genetics</topic><topic>Brain-Derived Neurotrophic Factor - metabolism</topic><topic>Cell Death - drug effects</topic><topic>Dizocilpine Maleate - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Interactions</topic><topic>Electrophoretic Mobility Shift Assay - methods</topic><topic>Enzyme Activation - drug effects</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Gene Expression Regulation, Enzymologic - drug effects</topic><topic>glutamate</topic><topic>Hippocampus - cytology</topic><topic>Hippocampus - drug effects</topic><topic>K-ATPase</topic><topic>Male</topic><topic>N-methyl-D-aspartate</topic><topic>N-Methylaspartate - pharmacology</topic><topic>Na,K‐ATPase</topic><topic>Neurons - cytology</topic><topic>Neurons - drug effects</topic><topic>NF-kappa B - metabolism</topic><topic>NF-κB</topic><topic>Nitric Oxide Synthase Type II - genetics</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Oligonucleotides - pharmacology</topic><topic>ouabain</topic><topic>Ouabain - pharmacology</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, N-Methyl-D-Aspartate - metabolism</topic><topic>RNA, Messenger - metabolism</topic><topic>Sodium-Potassium-Exchanging ATPase - metabolism</topic><topic>Time Factors</topic><topic>Tumor Necrosis Factor-alpha - genetics</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kawamoto, E.M.</creatorcontrib><creatorcontrib>Lima, L.S.</creatorcontrib><creatorcontrib>Munhoz, C.D.</creatorcontrib><creatorcontrib>Yshii, L.M.</creatorcontrib><creatorcontrib>Kinoshita, P.F.</creatorcontrib><creatorcontrib>Amara, F.G.</creatorcontrib><creatorcontrib>Pestana, R.R.F.</creatorcontrib><creatorcontrib>Orellana, A.M.M.</creatorcontrib><creatorcontrib>Cipolla-Neto, J.</creatorcontrib><creatorcontrib>Britto, L.R.G.</creatorcontrib><creatorcontrib>Avellar, M.C.W.</creatorcontrib><creatorcontrib>Rossoni, L.V.</creatorcontrib><creatorcontrib>Scavone, C.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawamoto, E.M.</au><au>Lima, L.S.</au><au>Munhoz, C.D.</au><au>Yshii, L.M.</au><au>Kinoshita, P.F.</au><au>Amara, F.G.</au><au>Pestana, R.R.F.</au><au>Orellana, A.M.M.</au><au>Cipolla-Neto, J.</au><au>Britto, L.R.G.</au><au>Avellar, M.C.W.</au><au>Rossoni, L.V.</au><au>Scavone, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus</atitle><jtitle>Journal of neuroscience research</jtitle><addtitle>J. Neurosci. Res</addtitle><date>2012-01</date><risdate>2012</risdate><volume>90</volume><issue>1</issue><spage>213</spage><epage>228</epage><pages>213-228</pages><issn>0360-4012</issn><eissn>1097-4547</eissn><abstract>It has been shown that ouabain (OUA) can activate the Na,K‐ATPase complex and mediate intracellular signaling in the central nervous system (CNS). Inflammatory stimulus increases glutamatergic transmission, especially at N‐methyl‐D‐aspartate (NMDA) receptors, which are usually coupled to the activation of nitric oxide synthase (NOS). Nuclear factor‐κB (NF‐κB) activation modulates the expression of genes involved in development, plasticity, and inflammation. The present work investigated the effects of OUA on NF‐κB binding activity in rat hippocampus and the influence of this OUA‐Na,K‐ATPase signaling cascade in NMDA‐mediated NF‐κB activation. The findings presented here are the first report indicating that intrahippocampal administration of OUA, in a concentration that did not alter Na,K‐ATPase or NOS activity, induced an activation of NF‐κB, leading to increases in brain‐derived neurotrophic factor (Bdnf), inducible NOS (iNos), tumor necrosis factor‐α (Tnf‐α), and B‐cell leukemia/lymphoma 2 (Bcl2) mRNA levels. This response was not linked to any significant signs of neurodegeneration as showed via Fluoro‐Jade B and Nissl stain. Intrahippocampal administration of NMDA induced NF‐κB activation and increased NOS and α2/3‐Na,K‐ATPase activities. NMDA treatment further increased OUA‐induced NF‐κB activation, which was partially blocked by MK‐801, an antagonist of NMDA receptor. These results suggest that OUA‐induced NF‐κB activation is at least in part dependent on Na,K‐ATPase modulatory action of NMDA receptor in hippocampus. The interaction of these signaling pathways could be associated with biological mechanisms that may underlie the basal homeostatic state linked to the inflammatory signaling cascade in the brain. © 2011 Wiley Periodicals, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>22006678</pmid><doi>10.1002/jnr.22745</doi><tpages>16</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0360-4012
ispartof Journal of neuroscience research, 2012-01, Vol.90 (1), p.213-228
issn 0360-4012
1097-4547
language eng
recordid cdi_proquest_miscellaneous_905671410
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Analysis of Variance
Animals
bcl-2-Associated X Protein - genetics
bcl-2-Associated X Protein - metabolism
Brain-Derived Neurotrophic Factor - genetics
Brain-Derived Neurotrophic Factor - metabolism
Cell Death - drug effects
Dizocilpine Maleate - pharmacology
Dose-Response Relationship, Drug
Drug Interactions
Electrophoretic Mobility Shift Assay - methods
Enzyme Activation - drug effects
Enzyme Inhibitors - pharmacology
Excitatory Amino Acid Antagonists - pharmacology
Gene Expression Regulation, Enzymologic - drug effects
glutamate
Hippocampus - cytology
Hippocampus - drug effects
K-ATPase
Male
N-methyl-D-aspartate
N-Methylaspartate - pharmacology
Na,K‐ATPase
Neurons - cytology
Neurons - drug effects
NF-kappa B - metabolism
NF-κB
Nitric Oxide Synthase Type II - genetics
Nitric Oxide Synthase Type II - metabolism
Oligonucleotides - pharmacology
ouabain
Ouabain - pharmacology
Proto-Oncogene Proteins c-bcl-2 - genetics
Proto-Oncogene Proteins c-bcl-2 - metabolism
Rats
Rats, Wistar
Receptors, N-Methyl-D-Aspartate - metabolism
RNA, Messenger - metabolism
Sodium-Potassium-Exchanging ATPase - metabolism
Time Factors
Tumor Necrosis Factor-alpha - genetics
Tumor Necrosis Factor-alpha - metabolism
title Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T15%3A04%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20N-methyl-D-aspartate%20receptors%20on%20ouabain%20activation%20of%20nuclear%20factor-%CE%BAB%20in%20the%20rat%20hippocampus&rft.jtitle=Journal%20of%20neuroscience%20research&rft.au=Kawamoto,%20E.M.&rft.date=2012-01&rft.volume=90&rft.issue=1&rft.spage=213&rft.epage=228&rft.pages=213-228&rft.issn=0360-4012&rft.eissn=1097-4547&rft_id=info:doi/10.1002/jnr.22745&rft_dat=%3Cproquest_cross%3E905671410%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=905671410&rft_id=info:pmid/22006678&rfr_iscdi=true